Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

568 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.
Turnbull F, Neal B, Algert C, Chalmers J, Chapman N, Cutler J, Woodward M, MacMahon S; Blood Pressure Lowering Treatment Trialists' Collaboration. Turnbull F, et al. Among authors: chapman n. Arch Intern Med. 2005 Jun 27;165(12):1410-9. doi: 10.1001/archinte.165.12.1410. Arch Intern Med. 2005. PMID: 15983291
Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.
Fransen M, Anderson C, Chalmers J, Chapman N, Davis S, MacMahon S, Neal B, Sega R, Terent A, Tzourio C, Woodward M; PROGRESS. Fransen M, et al. Among authors: chapman n. Stroke. 2003 Oct;34(10):2333-8. doi: 10.1161/01.STR.0000091397.81767.40. Epub 2003 Sep 4. Stroke. 2003. PMID: 12958329 Clinical Trial.
Progress in reducing the burden of stroke.
Chalmers J, Chapman N. Chalmers J, et al. Among authors: chapman n. Clin Exp Pharmacol Physiol. 2001 Dec;28(12):1091-5. doi: 10.1046/j.1440-1681.2001.03582.x. Clin Exp Pharmacol Physiol. 2001. PMID: 11903323
The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition.
Harrap SB, Tzourio C, Cambien F, Poirier O, Raoux S, Chalmers J, Chapman N, Colman S, Leguennec S, MacMahon S, Neal B, Ohkubo T, Woodward M; PROGRESS Collaborative Group. Harrap SB, et al. Among authors: chapman n. Hypertension. 2003 Sep;42(3):297-303. doi: 10.1161/01.HYP.0000088322.85804.96. Epub 2003 Aug 18. Hypertension. 2003. PMID: 12925557
Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk.
Ohkubo T, Chapman N, Neal B, Woodward M, Omae T, Chalmers J; Perindopril Protection Against Recurrent Stroke Sutdy Collaborative Group. Ohkubo T, et al. Among authors: chapman n. Am J Respir Crit Care Med. 2004 May 1;169(9):1041-5. doi: 10.1164/rccm.200309-1219OC. Epub 2004 Feb 27. Am J Respir Crit Care Med. 2004. PMID: 14990394 Clinical Trial.
Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region.
Rodgers A, Chapman N, Woodward M, Liu LS, Colman S, Lee A, Chalmers J, MacMahon S; Perindopril Protection against Recurrent Stroke Study Collaborative Group. Rodgers A, et al. Among authors: chapman n. J Hypertens. 2004 Mar;22(3):653-9. doi: 10.1097/00004872-200403000-00030. J Hypertens. 2004. PMID: 15076173 Clinical Trial.
568 results